Journal of the East Asian Society of Dietary Life (동아시아식생활학회지)

The East Asian Society of Dietary Life (동아시아식생활학회)
권호 표지

Effects of Black Soybean Supplement on Female Hormones, Serum Lipids and Risk of Cardiovascular Disease in Middle-aged Women

중년 여성에서 검은콩 보충 섭취가 여성 호르몬 및 혈중 지질 농도에 미치는 영향

  • Ko, Kyoung-Eh (Graduate School of Beauty Art, Youngsan University) ;
  • Kang, Ji-Yeon (Radiation Health Research Institute, Korea & Hydro Nuclear Power Co., Ltd.) ;
  • Han, Chae-Jeong (Deparment of Beauty Art, Youngsan University)
  • 고경애 (영산대학교 미용예술대학원) ;
  • 강지연 (한국수력원자력 방사선보건연구원) ;
  • 한채정 (영산대학교 미용예술학과)
  • Received : 2012.04.04
  • Accepted : 2012.06.19
  • Published : 2012.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

This study was aimed to investigate whether or not black soybean supplements affect levels of lipid profiles and female hormone (estradiol; E2, estrogen; Es) in 57 middle-aged women (in their 40s and 50s). All subjects were randomly assigned to the control or black soybean supplement group (BSS group). The BSS group was allocated to use dietary black soybean supplements (100 g/day) for 8 weeks. The BSS subjects were divided into two subgroups; 14 women were in the premenopausal group and 15 were in the postmenopausal group. We measured lipid profiles, female hormones and nutrient intakes at 0 weesk and 8 weeks. After 8 weeks, high-density lipoprotein (HDL) cholesterol was significantly decreased (P<0.01) and the athrogenic index (AI) was significantly increased (P<0.01) in control group. In BSS group, triglyceride (TG) (P<0.05), low-density lipoprotein (LDL) cholesterol (P<0.01) and LDL-HDL ratio (LHR) (P<0.01) were significantly decreased. However, E2 and Es were significantly increased (P<0.01). Compared to the control group, the BSS group revealed statistically significant improvements in the levels of TG, HDL-cholesterol, AI, LHR, E2 and Es (P<0.05). In the premenopausal group, HDL-cholesterol (P<0.05), E2 (P<0.01) and Es (P<0.05) were significantly increased and AI (P<0.01) and LHR (P<0.01) were significantly decreased after 8 weeks. In the postmenopausal group, E2 (P<0.05), and Es (P<0.05) were significantly decreased. However, total cholesterol (TC) was increased (P<0.01). Compared to the postmenopausal group, the premenopausal group was significantly improved on HDL-cholesterol, LDL-cholesterol and LHR (P<0.05). In conclusion, black soybean supplements may have beneficial effects on improving lipid profiles and female hormones.

Keywords

References

  1. Abdulnour J, Doucet E, Brochu M, Lavoie JM, Strychar I, Rabase- Lhoret R, Prud'homme D (2012) The effect of the menopausal transition on body composition and cardiometabolic risk fators: A Montreal-Ottawa New Emerging Team group study. Menopause 19: 760-767. https://doi.org/10.1097/gme.0b013e318240f6f3
  2. Adlercreutz H (1995) Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 103: 103-112.
  3. Adlercreutz H, Mazur W (1997) Phyto-estrogens and western disease. Ann Med 29: 95-120.
  4. Anderson JW, Johnstone BM, Cook-Newell ME (1995) Metaanalysis of the effects of soy protein intake on serum lipids. N Engl J Med 333: 276-282. https://doi.org/10.1056/NEJM199508033330502
  5. Bennett JO, Yu O, Heatherly LG, Krishnan HB (2004) Accumulation of genistein and daidzein, soybean isoflavones implicated in promoting human health is significantly elevated by irrigation. J Agric Food Chem 52: 7574-7579. https://doi.org/10.1021/jf049133k
  6. Beral V (2003) Breast cancer and hormone-replacement therapy in the Million women study. Lancet 362: 419-427. https://doi.org/10.1016/S0140-6736(03)14065-2
  7. Bittner V (2009) Menopause, age, and cardiovascular risk. A complex relationship. J Am Coll Cardiol 54: 2374-2375. https://doi.org/10.1016/j.jacc.2009.10.008
  8. Boulet M, Oddens B, Lehert P, Vermer H, Visser A (1994) Climacteric and menopausein seven south-east Asian countries. Maturitas 19: 157-176. https://doi.org/10.1016/0378-5122(94)90068-X
  9. Caldwell CR, Britz SJ, Mirecke RM (2005) Effect of temperature, elevated carbon dioxide, and drought during seed development on the isoflavone content of dwarf soybean [Glycine max (L.) Merrill] grown in controlled environments. J Agric Food Chem 53: 1125-1129. https://doi.org/10.1021/jf0355351
  10. Carmignani LO, Pedro AO, Costa-Paiva LH, Pinto-Neto AM (2010) The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: A randomized controlled trial. Maturitas 67: 262-269. https://doi.org/10.1016/j.maturitas.2010.07.007
  11. Cassidy A, Brown JE, Hawdon A, Faughnan MS, King LJ, Millward J, Zimmer-Nechemias L, Wolfe B, Setchell KD (2006) Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods. J Nutr 136: 45-51.
  12. Cheng G, Wilczek B, Warner M, Gustafsson JA, Landgren BM (2007) Isoflavone treatment for acute menopausal symptoms. Menopause 14: 468-473. https://doi.org/10.1097/GME.0b013e31802cc7d0
  13. Choi IS, Bea YJ, Jang S, Lee DH, Yun ME, Lee HS, Kim MH, Lee SH, Sung CJ (2005) Effect of soy isoflavone supplementation and exercise on serum lipid in postmenopausal women. Korean J Nutr 38:411-418.
  14. Cianci A, Cicero AF, Colacurci N, Matarazzo MG, De Leo V (2012) Activity of isoflavones and berberine on vasomotor symptoms and lipid profile in menopausal women. Gynecol Endocrinol 2012 Feb 8.
  15. Daly KT, Tracy AC, Malik M, Wang T, Francke-Carroll S, Magnuson BA (2007) Enhanced estrogenic responses and sensitivity to azoxymethane following dietary soy isoflavone supplementation in older female rats. Food Chem Toxicol 45: 628-637. https://doi.org/10.1016/j.fct.2006.10.021
  16. Derby CA, Crawford SL, Pasternak RC, Sowers M, Sternfeld B, Matthews KA (2009) Lipid changes during the menopause transition in relation to age and weight: the study of Women's Health Across the Nation. Am J Epidemiol 169: 1352-1361. https://doi.org/10.1093/aje/kwp043
  17. Dewell A, Hollenbeck CB, Bruce B (2002) The effects of soyderived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women. J Clin Endocrinol Metab 87: 118-121. https://doi.org/10.1210/jc.87.1.118
  18. Gwak JH, Kim JY, Kim HJ, Shin DH, Lee JH (2010) The effect of isoflavone and gamma-linolenic acid supplemetation on serum lipids and menopausal symptoms in postmenopausal women. Korean J Nutr 43: 123-131. https://doi.org/10.4163/kjn.2010.43.2.123
  19. Han KK, Soares JM Jr, Haidar MA, de Lima GR, Baracat EC (2002) Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet Gynecol 99: 389-394. https://doi.org/10.1016/S0029-7844(01)01744-6
  20. Hooper L, Ryder JJ, Kurzer MS, Lampe JW, Messina MJ, Phipps WR, Cassidy A (2009) Effects of soy protein and isoflavones on circulating hormone concentrations in preand post-menopausal women: A systematic review and metaanalysis. Hum Reprod Update 15: 423-440. https://doi.org/10.1093/humupd/dmp010
  21. Hwang CS, Kwak HS, Lim HJ, Lee SH, Kang YS, Choe TB, Hur HG, Han KO (2006) Isoflavone metabolites and their in vitro dual functions: they can act as as estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem Mol Biol 101: 246-253. https://doi.org/10.1016/j.jsbmb.2006.06.020
  22. Jensen LB, Vestergaard P, Hermann AP, Gram J, Eiken P, Abrahamsen B, Brot C, Kolthoff N, Sorensen OH, Beck- Nielsen H, Nielsen SP, Charles P, Mosekilde L (2003) Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: A randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study. J Bone Miner Res 18: 333-342. https://doi.org/10.1359/jbmr.2003.18.2.333
  23. Kavanaqh KK, Jones KL, Zhang L, Flynn DM, Shadoan MK, Wagner JD (2008) High isoflavone soy diet increases insulin secretion without decreasing insulin sensitivity in premenopausal nonhuman primates. Nutr Res 28: 368-376. https://doi.org/10.1016/j.nutres.2008.03.011
  24. Lee JH, Kim EM, Chae JS, Jang YS, Lee JH, Lee G (2003) The effect of isoflavone supplement on plasma lipid & antioxidant status in hypercholesterolemic postmenopausal women. Korean J Nutr 36: 603-612.
  25. Lee MJ, Sohn CY, Park OJ (2010) Relation between helath status and intake of soy isoflavone among adult women in Seoul. J East Asian Soc Dietary Life 20: 218-230.
  26. Lee SK, Lee MJ, Yoon S, Kwon DJ (2000) Estimated isoflavone intake from soy products in Korean middle-aged women. J Korean Soc Food Sci Nutr 29: 948-956.
  27. Maskarinec G, Singh S, Meng L, Franke AA (1998) Dietary soy intake and urine isoflavone excretion among women from multi-ethnic population. Cancer Epidemiol Biomarkers Prev 7: 613-669.
  28. Nelson HD, Haney E, Humphrey L, Miller J, Nedrow A, Nicolaidis C, Vesco K, Walker M, Bougatsos C, Nygren P (2005) Management of menopause-related symptoms. Evid Rep Technol Assess 120: 1-6.
  29. Patisaul HB, Dindo M, Whitten PL, Young LJ (2001) Soy isoflavone supplements antagonize reproductive behavior and estrogen receptor alpha- and beta- dependent gene expression in the brain. Endocrinology 142: 2946-2952. https://doi.org/10.1210/en.142.7.2946
  30. Potter SM (1995) Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 125: 606S-611S.
  31. Reynolds K, Chin A, Lees KA, Nguyen A, Bujnowski D, He J (2006) A meta-analysis of the effec of soy protein supplementation on serum lipids. Am J Cardiol 98: 633-640. https://doi.org/10.1016/j.amjcard.2006.03.042
  32. Seed M, Knopp RH (2004) Estrogens, lipoproteins, and cardiovascular risk factors. An update following the randomized placebo-controlled trials of hormone-replacement therapy. Curr Opinn Lipidol 15: 459-467. https://doi.org/10.1097/01.mol.0000137231.84772.80
  33. Seo MS (2002) Women's health problem in ministry of gender equality and family. Korean J Health Promot Dis Prev 2: 115-118.
  34. Somekawa Y, Chiguchi M, Ishibashi T, Aso T (2005) Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal women. Arch Intern Med 165: 1890-1895. https://doi.org/10.1001/archinte.165.16.1890
  35. Thiagarajan DG, Bennink MR, Bourquin LD, Kavas FA (1998) Prevention of precancerous colonic lesions in rats by soy flakes, soy flour, genistein, and calcium. Am J Clin Nutr 68: 1394S-1399S.
  36. U.S. Department of Agriculture (2008) USDA database for the isoflavone content of selected foods. USDA, Maryland. pp 26-27.
  37. Vigna GB, DonegàP, Zanca R, Barban A, Passaro A, Pansini F, Bonaccorsi G, Mollica G, Fellin R (2002) Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: A randomized, placebo-controlled clinical trial. Metabolism 51: 1463-1470. https://doi.org/10.1053/meta.2002.35584
  38. Wei P, Liu M, Chen Y, Chen DC (2012) Systematic review of soy isoflavone supplements on osteoporosis in women. Asian PAc J Trop Med 5: 243-248. https://doi.org/10.1016/S1995-7645(12)60033-9
  39. Weigt C, Hertrampf T, Zoth N, Fritzemeier KH, Diel P (2012) Impact of estradiol, ER subtype specific agonists and genistein on energy homeostasis in a rat model of nutrition induced obesity. Mol Cell Endocrinol 351: 227-238. https://doi.org/10.1016/j.mce.2011.12.013
  40. Women's Health Nursing Research Subject (2007) Women's health nursing care II (6th ed.). Soomoonsa, Seoul.
  41. Yeung J, Yu TF (2003) Effects of isoflavones (soy phytoestrogens) on serum lipids: A meta-analysis of randomized controlled trials. Nutr J 2: 15. https://doi.org/10.1186/1475-2891-2-15
  42. Zhan S, Ho SC (2005) Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 81: 397-408.